Gossamer Bio Catalyst Calendar
Proactively evaluate Gossamer Bio Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Gossamer Bio Catalyst Calendar data
| Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
|---|---|---|---|---|---|---|---|
| 30 Jun 2020 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
| 30 Jun 2020 | Phase II Trial Results | Gossamer Bio Inc; PPD Inc | GOSS | ADC-3680 | Respiratory | Asthma | Company Press Release |
| 01 Feb 2020 | Phase I Trial Completion | Gossamer Bio Inc | GOSS | GB-004 | Gastrointestinal | Ulcerative Colitis | Clinical Trial Registry |
| 31 Dec 2019 | Phase I Trial Results | Gossamer Bio Inc | GOSS | GB-004 | Gastrointestinal | Ulcerative Colitis | Investment Bank Report |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer